Latest News in the pharma Industry

All

Vertex to acquire CTP-656 from Concert Pharmaceuticals for the treatment of cystic fibrosis

Vertex to acquire CTP-656 from Concert Pharmaceuticals for the treatment of cystic fibrosis

6 Mar 2017

Vertex to develop CTP-656 for potential use in future combination regimens aimed at treating the underlying cause of CF.

Read more 
GSK study shows Nucala significantly improves quality of life and lung function in severe asthma patients

GSK study shows Nucala significantly improves quality of life and lung function in severe asthma patients

6 Mar 2017

Provides hope for patients with severe asthma, who currently have very limited treatment options.

Read more 
Sandoz proposed biosimilar adalimumab demonstrates equivalent efficacy as Humira

Sandoz proposed biosimilar adalimumab demonstrates equivalent efficacy as Humira

6 Mar 2017

Comprehensive development program show potential of GP2017 to treat inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.

Read more 
First ever biosimilar of interferon beta-1a approved in Russia

First ever biosimilar of interferon beta-1a approved in Russia

5 Mar 2017

Represents Biocad's third authorized medicine for the treatment of relapsing-remitting multiple sclerosis.

Read more 
CDMO invests in system to boost pharmaceutical formulation development

CDMO invests in system to boost pharmaceutical formulation development

5 Mar 2017

Alcami will use the D8 DISCOVER HTS to add XRD capabilities to their laboratory service portfolio.

Read more 
Allergopharma opens new biopharmaceutical production in Reinbek

Allergopharma opens new biopharmaceutical production in Reinbek

4 Mar 2017

Merck's €42 million investment expands the allergies business on a global scale.

Read more 
Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

4 Mar 2017

MEDI8897 has been engineered to have a long half-life so that only one dose would be needed for the entire RSV season.

Read more 
Contract manufacturer Pfizer CentreOne expands fill-finish services to its Kalamazoo, Michigan, facility

Contract manufacturer Pfizer CentreOne expands fill-finish services to its Kalamazoo, Michigan, facility

2 Mar 2017

Site provides vial-filling of small and large molecules plus sterile suspensions

Read more 
NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild-type mCRC

NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild-type mCRC

2 Mar 2017

More patients now able to receive a standard-of-care treatment with Erbitux plus Folfiri or Folfox.

Read more 
Roquette commits to bioharma market with new products

Roquette commits to bioharma market with new products

2 Mar 2017

Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries.

Read more 
Arquer Diagnostics awarded funding under Innovate UK’s Biocatalyst programme

Arquer Diagnostics awarded funding under Innovate UK’s Biocatalyst programme

2 Mar 2017

Funding will be used to prepare for international clinical study to evaluate the Company’s ELISA-based urine test for prostate cancer.

Read more 
Astellas and Affinivax announce worldwide partnership for MAPS vaccine targeting pneumococcal disease

Astellas and Affinivax announce worldwide partnership for MAPS vaccine targeting pneumococcal disease

2 Mar 2017

Affinivax’s MAPS vaccine technology overcomes the limitations of current conjugate vaccine technology, creating a MAPS pneumococcal vaccine that enables broader protection.

Read more